Rockwell Medical Technologies Inc. Reports Operating Results (10-Q)

Author's Avatar
May 07, 2012
Rockwell Medical Technologies Inc. (RMTI, Financial) filed Quarterly Report for the period ended 2012-03-31.

Rockwell Med has a market cap of $196.9 million; its shares were traded at around $8.4 with and P/S ratio of 4. Rockwell Med had an annual average earning growth of 7.5% over the past 5 years.

Highlight of Business Operations:

Sales in the first quarter of 2012 were $12.0 million compared to $13.3 million in the first quarter of 2011. Sales decreased $1.3 million or 9.5% largely due to reduced purchase volumes from one international distributor of $1.4 million partially offset by a $0.5 million increase in other international sales. Domestic sales were $0.4 million lower than the first quarter of last year primarily due to continuing changes in product mix resulting in lower sales dollars per unit as well as due to the loss of some smaller chain accounts that were acquired by other customers for whom we do not supply products. Over the last year, many customers have converted to our dry acid concentrate product line, which lowers providers cost per treatment and reduces our sales, but improves our gross profit margins by reducing shipping costs.

Gross profit margins in the first quarter of 2012 were 13.5% compared to 12.4% in the first quarter of 2011, an increase of 1.1 percentage points. Gross profit dollars in the first quarter were approximately equivalent to the first quarter of 2011 as changes to product mix, pricing and other costs offset the impact of lower sales volumes and higher fuel and material costs.

Read the The complete Report